ES455708A2 - Process of increasing the intravenous compatibility of gamma globulins - Google Patents

Process of increasing the intravenous compatibility of gamma globulins

Info

Publication number
ES455708A2
ES455708A2 ES455708A ES455708A ES455708A2 ES 455708 A2 ES455708 A2 ES 455708A2 ES 455708 A ES455708 A ES 455708A ES 455708 A ES455708 A ES 455708A ES 455708 A2 ES455708 A2 ES 455708A2
Authority
ES
Spain
Prior art keywords
tolerated
gamma
fractions
globulin
sheet silicates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES455708A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plasmesco AG
Original Assignee
Plasmesco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasmesco AG filed Critical Plasmesco AG
Publication of ES455708A2 publication Critical patent/ES455708A2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)

Abstract

A precipitate, which consists of fractions which are tolerated and those which are not tolerated by the body, of gamma-globulins precipitated from blood and blood products is chemically fractionated. The entire precipitate is for this purpose taken up or dissolved in an aqueous solution which contains macromolecular substances which are capable of uniting with the fractions which are not tolerated. The resulting aqueous solution containing gamma-globulin is then additionally mixed with a suspension of micaceous sheet silicates which have cation-exchange capacity. After a reaction time sufficient for the globulin fractions which are not tolerated to bind, by cation exchange, in the sheets of the sheet silicate has elapsed, a precipitating medium is added in order to remove the gamma-globulin fraction which separates out, together with the sheet silicates. Examples of suitable sheet silicates are bentonite, batavite and vermiculite, and an example of a suitable precipitating medium is polyethylene glycol.
ES455708A 1976-02-07 1977-02-07 Process of increasing the intravenous compatibility of gamma globulins Expired ES455708A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2604759A DE2604759C2 (en) 1976-02-07 1976-02-07 Method of Obtaining IV Compatible Gamma Globulins

Publications (1)

Publication Number Publication Date
ES455708A2 true ES455708A2 (en) 1978-01-16

Family

ID=5969262

Family Applications (1)

Application Number Title Priority Date Filing Date
ES455708A Expired ES455708A2 (en) 1976-02-07 1977-02-07 Process of increasing the intravenous compatibility of gamma globulins

Country Status (22)

Country Link
JP (1) JPS52117414A (en)
AT (1) AT351672B (en)
AU (1) AU508852B2 (en)
BE (1) BE851151R (en)
CA (1) CA1087524A (en)
CH (1) CH629669A5 (en)
DD (1) DD132758A6 (en)
DE (1) DE2604759C2 (en)
DK (1) DK151609C (en)
ES (1) ES455708A2 (en)
FI (1) FI62624C (en)
FR (1) FR2340738A2 (en)
GB (1) GB1577031A (en)
HU (1) HU177708B (en)
IE (1) IE44591B1 (en)
IN (1) IN144987B (en)
MX (1) MX5356E (en)
NL (1) NL7700975A (en)
PL (1) PL104234B3 (en)
SE (1) SE442707B (en)
YU (1) YU30577A (en)
ZA (1) ZA77684B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2837168A1 (en) * 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz METHOD FOR PRODUCING AN IMMUNAL GLOBULIN SOLUTION SUITABLE FOR INTRAVENOUS APPLICATION
JPS60222773A (en) * 1984-04-19 1985-11-07 Sekisui Chem Co Ltd Manufacture of latex reagent
EP0168506B2 (en) * 1984-07-07 1998-01-07 Armour Pharma GmbH Process for preparing gamma globulin suitable for intravenous administration
DE3440444A1 (en) * 1984-11-06 1986-05-07 Dechema Deutsche Gesellschaft für chemisches Apparatewesen e.V., 6000 Frankfurt METHOD FOR THE PRODUCTION OF COARSE GRAINED LAYERED SILICATES AND THE USE THEREOF AS ADSORBENTS FOR PROTEINS
UA64742C2 (en) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн Process for producing intravenously-administrable gamma globulin solution and product manufactured by this process
EP3118210B1 (en) 2014-03-11 2019-11-13 Green Cross Holdings Corporation Method for purifying immunoglobulin
EP3118209B1 (en) 2014-03-11 2020-02-19 Green Cross Holdings Corporation Method for purifying immunoglobulin
KR101657690B1 (en) 2015-06-05 2016-09-19 주식회사 녹십자홀딩스 Methods for Preparing Hepatitis B immune globulin derived from plasma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449316A (en) * 1967-03-03 1969-06-10 American Cyanamid Co Process for the purification of gamma globulin employing bentonite
DE2500076C3 (en) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Process for the production of intravenously tolerated gamma globulins

Also Published As

Publication number Publication date
DE2604759A1 (en) 1977-09-29
MX5356E (en) 1983-06-29
DK151609C (en) 1988-06-20
DE2604759C2 (en) 1983-06-01
DK151609B (en) 1987-12-21
FR2340738A2 (en) 1977-09-09
ZA77684B (en) 1977-12-28
FI62624B (en) 1982-10-29
SE442707B (en) 1986-01-27
SE7700960L (en) 1977-08-08
AU508852B2 (en) 1980-04-03
HU177708B (en) 1981-12-28
DD132758A6 (en) 1978-11-01
FI62624C (en) 1983-02-10
DK47277A (en) 1977-08-07
IN144987B (en) 1978-08-05
AT351672B (en) 1979-08-10
FR2340738B2 (en) 1981-07-31
AU2190277A (en) 1978-08-10
JPS52117414A (en) 1977-10-01
CA1087524A (en) 1980-10-14
FI770290A (en) 1977-08-08
IE44591L (en) 1977-08-07
PL104234B3 (en) 1979-08-31
JPS6231695B2 (en) 1987-07-09
YU30577A (en) 1984-04-30
IE44591B1 (en) 1982-01-27
ATA74177A (en) 1979-01-15
GB1577031A (en) 1980-10-15
BE851151R (en) 1977-08-04
CH629669A5 (en) 1982-05-14
NL7700975A (en) 1977-08-09

Similar Documents

Publication Publication Date Title
ZA796880B (en) Agent for the detetction of leukocytes in body fluids
BE839881A (en) PERFECTED PROCESS FOR THE RECOVERY OF ETHYLENE OXIDE
ES455708A2 (en) Process of increasing the intravenous compatibility of gamma globulins
GB1506555A (en) Blood reservoir
GB1495159A (en) Process reducing the anticomplementary activity of gamma globulins
NL7508653A (en) PROCEDURE FOR PREVENTING THE DEVELOPMENT OF NITRUS VAPORS IN DISSOLVING VALUABLE METALS IN SALPETERIC ACID CONTAINING MINERAL ACID.
CA943049A (en) Process for the determination of the hydroxyproline content of biological fluids, and diagnostic packs for this determination
JPS52104397A (en) Facility for purifying blood or like corrosive liquid
ES8604694A1 (en) Iodothyronine immunoassays employing HMS as TBP blocking agent.
GB1188396A (en) Treatment of Radioactive Liquids
FR2424046B1 (en) PROCESS FOR PURIFYING LIQUIDS AND / OR REGENERATING ABSORBENT SOLUTIONS
GB1055896A (en) Silica adsorbents in interferon purification and/or concentration
NL181861C (en) CONNECTION BETWEEN BOLTS, IN PARTICULAR FOR ASSEMBLING HULLS OF VESSELS.
NL7604048A (en) PROCESS FOR THE BIOLOGICAL PURIFICATION OF CARBON HYDRATE OR PROTEIN CONTAINING WASTE WATER.
JPS5628766A (en) Activated carbon for purifying blood
DK374082A (en) REGENERATION OF ORGANOPHOSPHATE LIQUIDS
NL7812471A (en) PROCESS FOR THE SEPARATION OF GAS OR VAPOR-FORMULAS, ESPECIALLY ISOTOPES.
JPS56145858A (en) Purifier for body fluid
DE3361628D1 (en) Substituted 5-phenylthio-6-amino-pyrimidinones, process for their preparation and their use, and preparations containing these compounds
NL169986C (en) TANK FOR MELTING, PURIFYING AND CONDITIONING GLASS.
GB1135279A (en) Process for purifying aliphatic glycols which are contaminated by oxidation products
JPS54118697A (en) Membrane for treating body fluids
CA892471A (en) Mehod for purifying and agglomerating pyrite cinders
CA856568A (en) Dialysis means for purifying blood or other liquids
Hsu et al. Hapalemur griseus griseus. Hapalemur griseus olivaceus: Gentle lemurs